Glen Kristiansen

40PUBLICATIONS
135CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMedical biotechnology diagnostics (incl. biosensors)Molecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|May 20, 2026
Nectin-4 immunohistochemistry distinguishes urothelial carcinoma in situ from reactive urothelium.

|Jan 18, 2026
Prevalence and clinico-morphological correlates of STK11 mutations in a large cohort of NSCLC lung adenocarcinomas.

Rizvan Rustamov, László Füzesi, Thomas Lesser

|Dec 18, 2025
[ISUP 1 Prostate Carcinoma Controversy: Is the Term Carcinoma Justified - Clinical or Anatomical Definition?]

Glen Kristiansen, Marit Bernhardt, Phillip Krausewitz

|Dec 12, 2025
The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate.

Rajal B Shah, Murali Varma, Ming Zhou

|Sep 04, 2025
ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis.

Mohsin Raza, Asher Rajkumar Rajan, Benjamin B Kennedy

|Jun 27, 2025
Low heterogeneity of tumor grades in multiple MRI-targeted prostate biopsies argues for the aggregate method of grading.

Oliver Hommerding, Fereschte Sara Rejai, Anna Scherping

Pageof 7

Frequent Collaborators

5 joint publications

Marieta Toma

5 joint publications

Niklas Klümper

4 joint publications

Damian J Ralser

4 joint publications

Geert van Leenders